Mom's Environment During Pregnancy can Affect her Grandchildren
By Jocelyn Kaiser,
Science
| 07. 10. 2014
Untitled Document
Starving a pregnant mouse can cause changes in the sperm of her sons that apparently warp the health of her grandchildren, according to a new study. The finding offers some of the strongest evidence yet that a mother’s environment during pregnancy can alter the expression of DNA in ways that are passed on to future generations.
A number of studies have suggested that environmental stresses in a parent may harm the health of subsequent generations. For example, women who were pregnant during a 1944 famine in the Netherlands known as the Dutch Hunger Winter had children and grandchildren who were unusually small or prone to diabetes and obesity. Animal studies have also found that a stress to a parent, such as exposing a pregnant mouse to toxic chemicals or mildly shocking a mouse father to make it fear an odor, can result in effects such as infertility or changes in behavior that persist for two generations or more yet can’t be explained by genetic mutations.
Some scientists suspect that the effects are passed down via so-called...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...